OVARIAN MALIGNANCY may result in the accumulation of ascitic fluid in the peritoneal cavity. This fluid is similar in composition to serum and is in immediate contact with the tumour. Dorsett et al. (1975) show that this fluid contains tumourassociated immunoglobulin. In the present study, IgG was isolated from ascitic fluids in an attempt to detect tumour antigen in the patient's serum.
Five litres of ascitic fluid were obtained by paracentesis from a 58-year-old female patient with serous cystadenocarcinoma of the ovary. The fluid was immediately centrifuged 1000 g at 4°C, and stored at -15TC. Ascitic fluid from 3 other female patients at similar clinical stages of malignancy (Stage III) was similarly treated.
IgG was separated from the ascitic fluid by column chromatography, using QAE Sephadex (Pharmacia, Sweden) ethylene diamine acetate buffer at pH 7 0. ionic strength 0 1 in a 41 column (120 cm X 7-0 cm) at 20TC (Joustra and Lunderen, 1969) .
This was capable of separating in a singlestep procedure, the IgG fraction from 11 of ascitic fluid. The separation of the IgG fraction was monitored visually, using agar-gel electrophoretic plates (Corning Ltd., California, U.S.A.). The electrophoresis was carried out using 10 al of the column effluent at 20°C in 0 05 M barbitone buffer, pH . The plates were stained with 0-1 0% Coomassie blue in ethanol, acetic acid and water (5:1:4) for 10 min [16] [17] [18] h. The plates were stained and destained as previously described in this article.
An allogeneic ovarium serous cystadenocarcinoma, a spontaneously aborted 16-week-old foetus, and a normal allogeneic ovary were homogenized separately in phosphate-buffered saline (PBS) pH 7-2, using a tissue homogenizer. The homogenates were then extracted with 1 0 M perchloric acid (PCA) and centrifuged 4000 g at 4°C, and the supernatant was freeze dried at 0-1 mmHg for 12 h. The PCA extract was then reconstituted at 5 g/100 ml in 0-2 M PBS, pH 7-2. Ascitic fluids (300 ml) from the 4 patients were similarly treated with PCA. The supernatant was concentrated using an Amicon UM 10 (mol. wt retention limit 10,000) filter (Amicon, Mass., U.S.A.) until the protein concentration reached 70 mg/ml as determined by the Folin method.
The isolated IgG fraction gave a positive reaction in the Ouchterlony (1958) diffusion test against pooled normal human serum. The reaction was probably due to blood-group antigens and antibodies, so the isolated IgG fraction was absorbed against pooled normal human serum (Avrameas and Ternynck, 1969) . The success of this treatment was determined by the failure of the isolated IgG fraction to give a positive reaction in the Ouchterlony (1958) diffusion test against normal pooled human serum. This method for assessing antigen-antibody reactions was used throughout the study. Plates were prepared using Agarose (Biorad, California) 1 g/100 ml in 0 05 M barbitone buffer, pH 8-6, and diffusion carried out for 16-18 h at 230C. Staining and destaining was carried out as previously described in this article. To the plates, 10 pl (500 ,tg protein) of the isolated IgG was allowed to react with 10 pi of pooled normal human serum, 10 pI (500 ,g protein) extracts of an allogeneic ovarian serous cystadenocarcinoma, normal ovarian tissue, 16-week-old foetus and 10 1l (700 ,tg protein) PCA-treated and untreated autologous and heterologous ascitic fluids.
The inhibitory effect of the isolated IgG in a micro-radioimmunoassay for carcinoembryonic antigen (CEA) was determined (MacSween et al., 1972) . Briefly, the method employs double antibody precipitation and the residual radioactivity is counted in the supernatant. The limit of sensitivity of the assay is 3 ng/ml CEA. The concentration of IgG used in the assay was 500 ,ug of protein in 10 pl.
Serum and ascitic fluid from the patient from whom the IgG was isolated, including the isolated IgG, were tested for rheumatoid factor, using the Latex-RF-Reagenz kit (Behringwerke A.G., West Germany). The concentration of IgG used was 500 Hg protein in 10 pl.
The purified ascitic-fluid IgG was reacted with the serum, ascitic fluid and PCA extracts of ascitic fluid from the 4 cancer patients, as well as with the PCA extracts of an allogeneic ovarian tumour, a whole foetus and an allogeneic ovary.
Serum, ascitic fluid and a PCA extract of ascitic fluid of the patient from whom the IgG was isolated, reacted with this IgG ( Figs. 1 and 2 ). The PCA extract of the allogeneic ovarian serous cystadenocarcinoma also reacted with this IgG (Fig.  2) . The serum, ascitic fluid and PCA ascitic fluid extracts from the 3 other patients did not react with the isolated IgG, neither did the PCA extract of the whole foetus, nor the PCA extract of the normal allogeneic ovary.
In the radioimmunoassay for CEA, the addition of the isolated IgG did not have a significant inhibitory effect on the assay (Table) .
Rheumatoid-factor-like activity could not be detected in the serum or ascitic fluid of the patient from whom the IgG was isolated. In addition, the isolated IgG was shown not to have rheumatoid-factor activity.
The reactivity of IgG with the patient's serum and ascitic fluid, suggests that antibody or antibodies have been produced in response to the tumour. This further suggests that the antigen(s) responsible for eliciting this humoral response is not a normal phase-specific component, since antibodies are not normally elicited by such components to the extent that they can be detected by immunodiffusion. In addition, the IgG did not react with a PCA extract of foetal tissue or inhibit the radioimmunoassay for CEA. The IgG did not react with a PCA extract of normal allogeneic ovarian tissue, but did react with a PCA extract of an allogeneic serous cystadenocarcinoma. Therefore, it is possible that the antigen(s) involved in eliciting a humoral response in this patient is tumour-specific. It may be shared by other carcinomas, as in the case of ovarian cystadenocarcinoma and squamous-cell carcinoma of the cervix (Bhattacharya et al., 1974) . The failure of the IgG to react with the serum or ascitic fluid from patients with similar malignancies may be a reflection of the low levels of circulating antigen(s) in these patients.
The use of xenogeneic antisera in the detection of malignant neoplasms may result in the detection of phase-specific antigens which are present in normal tissue in trace amounts. For example, carcinoembryonic antigen (CEA) is present in normal plasma (Chu et al., 1972) as well as in colon and lung (Lo Gerfo and Herter, 1972) . Other oncofoetal antigens have been found (Takahashi et al., 1967; Buffe et al., 1968; Hakkinen and Viikari, 1969; Purves et al., 1970; Edynak et al., 1972; Banwo et al., 1974) but none is tumour specific. The identification of tumour-specific antigens would obviously be of value in the diagnosis of malignant neoplasms.
